Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A user plans a drug-free hair transplant while waiting for future treatments like stem cell therapies, which are projected to be available between 2028 and 2030. Many users express skepticism about the availability of new treatments, suggesting that relying on them is risky and that finasteride remains the most effective option.

PP405 shows promise in reactivating dormant hair follicles, with early trials indicating some success, but it is not yet a proven treatment for hair loss. Users are advised to be cautious with unverified versions, and further research is needed to confirm its effectiveness compared to treatments like minoxidil and finasteride.

RU58841 is debated for hair loss treatment; some users report positive results, while others find it ineffective or risky. It is not widely marketed due to limited effectiveness, safety concerns, and competition from existing treatments like finasteride and minoxidil.

Using 1.5mg dutasteride, 2.5mg oral minoxidil, and topical RU58841 may help manage hair loss while on testosterone, but regrowth is uncertain. Users report varying success with different dosages and combinations of these treatments.

Many users report not experiencing a shedding phase while using finasteride, with some also using minoxidil or dutasteride without shedding. Some believe shedding might be mistaken for normal hair loss, while others note micro sheds or no shedding at all.

The user experienced significant hair loss after PRP sessions and is now using minoxidil and finasteride to recover. Many users express skepticism about PRP's effectiveness, suggesting consistency with minoxidil and finasteride is key.

A 19-year-old male is experiencing hair shedding while using oral minoxidil, ketoconazole, dermastamping, and saw palmetto, and is considering switching to finasteride for better results. Users suggest that saw palmetto may not be effective and recommend finasteride instead, while also discussing other treatments like rosemary oil, peppermint oil, and pumpkin seed oil.

People are discussing the affordability and effectiveness of Indian generic medications for hair loss, specifically oral dutasteride and minoxidil. They mention brands like Dr. Reddy's, Cipla, and KLM, and discuss payment challenges when purchasing from India.

Taking Finasteride and Minoxidil daily is compared to routine tasks, with some users emphasizing the benefits and minimal time commitment, while others express concerns about side effects, medication access, and dependency. Opinions vary on the importance of hair preservation versus potential risks, with some users willing to accept risks for better hair.

Breezula is seen as a potential future treatment for hair loss, but its release is uncertain and current data is limited. Other treatments like GT20026 and pyrilutamide are discussed, but skepticism remains about their effectiveness compared to established options like finasteride and minoxidil.

The conversation discusses the legitimacy and reputation of various Indian brands of dutasteride, with recommendations for Dr. Reddy's, Cipla's Duprost, and Intas's Veltride/Dutaman as reputable options. The company in question is noted for exporting but is not well-known locally, though it adheres to global standards.

JXL069, also known as PP405, did not lead to hair regrowth after a year of testing. The lack of results may be due to formulation issues, leading to a final attempt with an improved vehicle.

Hair loss treatments like topical Minoxidil with Finasteride and Dutasteride are discussed, highlighting their low prices in India. The conversation also touches on the affordability of medications in India due to mass production and government subsidies.

The user is seeking a gentle, fragrance-free daily shampoo for a sensitive scalp with mild psoriasis, considering options like Cleure, CeraVe, and Vanicream. They are also contemplating using Nizoral once a week despite concerns about its harshness.

PP405 and JXL069 are confirmed to be the same molecule, leading to disappointment due to poor hair regrowth results. Users express skepticism about the credibility of Pelage and the effectiveness of JXL069.

Suvomipic, previously known as PP405, is progressing to Phase 3 trials for hair loss treatment. Its effectiveness compared to existing treatments like Minoxidil and Finasteride is still uncertain.

Finasteride is expensive in Europe, with users suggesting buying 5mg pills and splitting them to save money. Prices vary by country, and some recommend using telemedicine or buying from other countries to reduce costs.

A 27-year-old male shared progress on hair density improvement after 18 months of using oral finasteride (1mg) and oral minoxidil (2.5mg) daily, with no side effects reported. He also reduced alcohol consumption and improved overall health, noticing results around 8 months in.

The conversation discusses using finasteride for hair loss and its side effect of erectile dysfunction (ED), with some users suggesting reducing the dose to 0.5mg to minimize side effects. Cialis is recommended for managing ED, and other suggestions include monitoring hormone levels and considering supplements like DIM or L-Citrulline.

Prolactin may contribute to hair loss, but targeting its receptor won't cure androgenetic alopecia. ABS-201 could be a useful alternative or adjuvant therapy, similar to JAK inhibitors, but not more effective than HMI-115.

Breezula is discussed as a potential topical anti-androgen treatment for hair loss, with mixed opinions on its effectiveness and side effects compared to other treatments like finasteride, minoxidil, and RU58841. Some users express skepticism about its long-term efficacy and potential side effects, while others are hopeful for its approval and use in combination with existing treatments.

The conversation discusses purchasing finasteride tablets at a low cost in India, with users recommending reputable brands like Cipla and Intas over Zeelab due to quality concerns. Alternatives like MedPlus and Davaindia are suggested, and users share experiences with various brands, emphasizing the importance of quality over price.

Amplifica is developing new molecules for hair growth, with clinical trials expected soon, while Engraft Technologies is improving FUE robotic technology to make hair transplants faster and cheaper. Users express interest in the timeline for AMP-303 and concerns about high costs and effectiveness of current treatments.

A user experienced hair shedding after stopping and restarting topical minoxidil due to side effects like facial edema and hirsutism. They are considering alternatives like low-dose oral minoxidil, PRP, and red light therapy, while others suggest finasteride and caution against combining multiple treatments without medical advice.

Pattern hair loss before age 35 may be linked to higher risks of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life. Finasteride is discussed as a treatment that may lower PSA levels and potentially prevent prostate issues.

A plant-based diet focused on anti-inflammation may help reduce hair loss when medications like finasteride and dutasteride are ineffective. Improving artery health through diet and exercise could be a potential solution for those who do not respond to medication.

The user has been using oral finasteride for over a year and recently added GHK-CU for two months, seeing progress but seeking further improvement, especially on the hairline. They discuss sourcing GHK-CU, its effects, and the importance of third-party testing, while considering additional treatments like dutasteride and hair transplants for better results.

Hair loss is largely influenced by genetics, with treatments like finasteride, minoxidil, and RU58841 being used to manage it. Despite healthy lifestyles, hair loss can still occur, highlighting the complex relationship between genetics, health, and aging.

The user is experiencing hair regrowth after 4.5 months of using oral minoxidil, oral dutasteride, latanoprost, ketoconazole shampoo, and dermarolling. They report shedding initially but have seen improvement without significant side effects.

PP405 is the most promising future treatment for hair loss, aiming to reactivate dormant hair follicles. Clascoterone 5% is the most promising near-term drug, while current strategies include using finasteride or dutasteride to stabilize hair loss and minoxidil to stimulate growth.